載入...
Wnt antagonist FRZB is a muscle biomarker of denervation atrophy in amyotrophic lateral sclerosis
Skeletal muscle and the neuromuscular junction are the earliest sites to manifest pathological changes in amyotrophic lateral sclerosis (ALS). Based on prior studies, we have identified a molecular signature in muscle that develops early in ALS and parallels disease progression. This signature repre...
Na minha lista:
| 發表在: | Sci Rep |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Nature Publishing Group UK
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7541525/ https://ncbi.nlm.nih.gov/pubmed/33028902 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-73845-z |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|